Class I HDACs specifically regulate E‐cadherin expression in human renal epithelial cells
暂无分享,去创建一个
M. Jeong | F. Hansen | T. Kurz | Li Jin | Yuhee Ryu | Z. Piao | S. Y. Choi | G. Kim | H. Kee | M. Q. Lin
[1] Hyung-Seok Kim,et al. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. , 2015, Vascular pharmacology.
[2] S. Park,et al. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. , 2015, Oncology reports.
[3] S. Zhuang,et al. Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling , 2013, PloS one.
[4] H. Gohlke,et al. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. , 2013, Journal of medicinal chemistry.
[5] E. Olson,et al. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development , 2012, Proceedings of the National Academy of Sciences.
[6] L. Kenner,et al. Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis , 2011, Cell cycle.
[7] Jianguo Song,et al. Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition. , 2010, The international journal of biochemistry & cell biology.
[8] Merlin C. Thomas,et al. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology , 2010, Expert Reviews in Molecular Medicine.
[9] S. Zhuang,et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. , 2009, American journal of physiology. Renal physiology.
[10] Ji Yeon Seo,et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. , 2009, American journal of physiology. Renal physiology.
[11] G. Wolf,et al. TGF-beta and fibrosis in different organs - molecular pathway imprints. , 2009, Biochimica et biophysica acta.
[12] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[13] Emily J. Greenspan,et al. HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling , 2008, Cancer biology & therapy.
[14] J. Lasky,et al. Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition* , 2008, Journal of Biological Chemistry.
[15] A. Leask. TGFβ, cardiac fibroblasts, and the fibrotic response , 2007 .
[16] Tiegang Liu,et al. Smooth muscle α‐actin expression and myofibroblast differentiation by TGFβ are dependent upon MK2 , 2007 .
[17] I. Adcock. HDAC inhibitors as anti‐inflammatory agents , 2007, British journal of pharmacology.
[18] Y. Shimono,et al. Enhancer of Polycomb1, a Novel Homeodomain Only Protein-binding Partner, Induces Skeletal Muscle Differentiation* , 2007, Journal of Biological Chemistry.
[19] M. Rastaldi. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. , 2006, Journal of nephrology.
[20] A. Garg,et al. Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.
[21] J. Vieira,et al. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] Ricardo Macarron,et al. Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases , 2003, Journal of Pharmacology and Experimental Therapeutics.
[23] E. Neilson,et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.
[24] Ping Zhu,et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.
[25] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[26] J. Yamate,et al. Macrophages, Myofibroblasts, and Extracellular Matrix Accumulation in Interstitial Fibrosis of Chronic Progressive Nephropathy in Aged Rats , 1998, Veterinary pathology.
[27] M. Pichler,et al. Epigenetic control of epithelial-mesenchymal-transition in human cancer. , 2013, Molecular and clinical oncology.
[28] P. Kantharidis,et al. The role of EMT in renal fibrosis , 2011, Cell and Tissue Research.
[29] T. Fujita,et al. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. , 2007, Journal of the American Society of Nephrology : JASN.